Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
Abstract Background The incidence of maternal opioid use in the USA has increased substantially since 2000. As a consequence of opioid use during pregnancy, the incidence of neonatal opioid withdrawal syndrome (NOWS) has increased fivefold between 2002 and 2012. Pharmacological therapy is indicated...
Main Authors: | Adam Czynski, Abbot Laptook, Abhik Das, Brian Smith, Alan Simon, Rachel Greenberg, Robert Annett, Jeannette Lee, Jessica Snowden, Claudia Pedroza, Barry Lester, Barry Eggleston, Drew Bremer, Elisabeth McGowan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-023-07378-x |
Similar Items
-
Neural mechanisms underlying morphine withdrawal in addicted patients: a review
by: Nima Babhadiashar, et al.
Published: (2015-07-01) -
Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome
by: Dorothea D. Jenkins, et al.
Published: (2021-03-01) -
Neonatal opioid withdrawal syndrome and implications for pain assessment in the newborn: a scoping review
by: Sriya Roychaudhuri, et al.
Published: (2024-03-01) -
Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS)
by: Sarah Stevens, et al.
Published: (2021-04-01) -
Simvastatin prevents morphine antinociceptive tolerance and withdrawal symptoms in rats
by: Fatemeh Ghasemi, et al.
Published: (2015-05-01)